एपीए उद्धरण

Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Brochet, B., Naismith, R. T., . . . Montalban, X. (2020). Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension. Neurology.

शिकागो स्टाइल उद्धरण

Hauser, Stephen L., et al. "Five Years of Ocrelizumab in Relapsing Multiple Sclerosis: OPERA Studies Open-label Extension." Neurology 2020.

एमएलए उद्धरण

Hauser, Stephen L., et al. "Five Years of Ocrelizumab in Relapsing Multiple Sclerosis: OPERA Studies Open-label Extension." Neurology 2020.